{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:17:12Z","timestamp":1707524232082},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,3,1]]},"DOI":"10.7759\/cureus.13638","type":"journal-article","created":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T17:27:49Z","timestamp":1614619669000},"source":"Crossref","is-referenced-by-count":0,"title":["Red Blood Cell Exchange in a Patient With Extramedullary Hematopoiesis and Cor Pulmonale Secondary to Beta Thalassemia"],"prefix":"10.7759","author":[{"given":"Pallavi","family":"Kopparthy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amar H","family":"Kelkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunal","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samantha","family":"De Filippis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20269","article-title":"Molecular genetic confirmatory testing from newborn screening samples for the common African-American, Asian Indian, Southeast Asian, and Chinese beta-thalassemia mutations","volume":"78","author":"Bhardwaj U","year":"2005","unstructured":"Bhardwaj U, Zhang YH, Lorey F, McCabe LL, McCabe ER. Molecular genetic confirmatory testing from newborn screening samples for the common African-American, Asian Indian, Southeast Asian, and Chinese beta-thalassemia mutations. Am J Hematol. 2005, 78:249-55. 10.1002\/ajh.20269","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/GIM.0b013e3181cd68ed","article-title":"Beta-thalassemia","volume":"12","author":"Cao A","year":"2010","unstructured":"Cao A, Galanello R. Beta-thalassemia. Genet Med. 2010, 12:61-76. 10.1097\/GIM.0b013e3181cd68ed","journal-title":"Genet Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0169-6009(91)90142-m","article-title":"Bone disease in children with homozygous beta-thalassemia","volume":"8","author":"Rioja L","year":"1990","unstructured":"Rioja L, Girot R, Garabedian M, Cournot-Witmer G. Bone disease in children with homozygous beta-thalassemia. Bone Miner. 1990, 8:69-86. 10.1016\/0169-6009(91)90142-m","journal-title":"Bone Miner"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/BF00296768","article-title":"Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine","volume":"50","author":"Orvieto R","year":"1992","unstructured":"Orvieto R, Leichter I, Rachmilewitz EA, Margulies JY. Bone density, mineral content, and cortical index in patients with thalassemia major and the correlation to their bone fractures, blood transfusions, and treatment with desferrioxamine. Calcif Tissue Int. 1992, 50:397-399. 10.1007\/BF00296768","journal-title":"Calcif Tissue Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(89)90264-x","article-title":"Survival and causes of death in thalassaemia major","volume":"8653","author":"Zurlo MG","year":"1989","unstructured":"Zurlo MG, De Stefano P, Borgna-Pignatti C, et al.. Survival and causes of death in thalassaemia major. Lancet. 1989, 8653:27-30. 10.1016\/s0140-6736(89)90264-x","journal-title":"Lancet"},{"key":"ref6","article-title":"Pulmonary thromboembolism in thalassemic patients","volume":"23","author":"Sonakul D","year":"1992","unstructured":"Sonakul D, Fucharoen S. Pulmonary thromboembolism in thalassemic patients. Southeast Asian J Trop Med Public Health. 1992, 23:25-28.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-130-6-199903160-00014","article-title":"Pulmonary hypertension after splenectomy?","volume":"130","author":"Hoeper MM","year":"1999","unstructured":"Hoeper MM, Niedermeyer J, Hoffmeyer F, Flemming P, Fabel H. Pulmonary hypertension after splenectomy?. Ann Intern Med. 1999, 130:506-509. 10.7326\/0003-4819-130-6-199903160-00014","journal-title":"Ann Intern Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1046\/j.1537-2995.1997.37297203514.x","article-title":"A moderate transfusion regimen may reduce iron loading in \u03b2-thalassemia major without producing excessive expansion of erythropoiesis","volume":"37","author":"Cazzola M","year":"1997","unstructured":"Cazzola M, Bornga-Pignatti C, Locatelli F, Ponchio L, Beguin Y, De Stefano P. A moderate transfusion regimen may reduce iron loading in \u03b2-thalassemia major without producing excessive expansion of erythropoiesis. Transfusion. 1997, 37:135-140. 10.1046\/j.1537-2995.1997.37297203514.x","journal-title":"Transfusion"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1098-1101(1999)14:3<122::aid-jca3>3.0.co;2-a","article-title":"Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload","volume":"14","author":"Singer ST","year":"1999","unstructured":"Singer ST, Quirolo K, Nishi K, Hackney\u2010Stephens E, Evans C, Vichinsky EP. Erythrocytapheresis for chronically transfused children with sickle cell disease: an effective method for maintaining a low hemoglobin S level and reducing iron overload. J Clin Apher. 1999, 14:122-125. 10.1002\/(sici)1098-1101(1999)14:3&lt;122::aid-jca3&gt;3.0.co;2-a","journal-title":"J Clin Apher"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V89.3.739","article-title":"Iron-chelating therapy and the treatment of thalassemia","volume":"89","author":"Olivieri NF","year":"1997","unstructured":"Olivieri NF, Brittenham GM. Iron-chelating therapy and the treatment of thalassemia. Blood. 1997, 89:2621.","journal-title":"Blood"},{"key":"ref11","article-title":"Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT), 3rd edition","year":"2014","unstructured":"Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT), 3rd edition. Cappellini MD, Cohen A, Porter J, Taher A, Viprakasit V (ed). Thalassaemia International Federation, Nicosia; 2014."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199801293380501","article-title":"Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension","volume":"338","author":"McLaughlin VV","year":"1998","unstructured":"McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med. 1998, 338:273-277. 10.1056\/NEJM199801293380501","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul H","year":"2021","unstructured":"Frangoul H, Altshuler D, Cappellini MD, et al.. CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia. N Engl J Med. 2021, 384:252-260. 10.1056\/NEJMoa2031054","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1910182","article-title":"A phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia","volume":"382","author":"Cappellini MD","year":"2020","unstructured":"Cappellini MD, Viprakasit V, Taher AT, et al.. A phase 3 trial of luspatercept in patients with transfusion-dependent \u03b2-thalassemia. N Engl J Med. 2020, 382:1219-31. 10.1056\/NEJMoa1910182","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-8703(97)70091-7","article-title":"Pulmonary hypertension in patients with thalassemia major","volume":"134","author":"Du ZD","year":"1997","unstructured":"Du ZD, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997, 134:532-537. 10.1016\/s0002-8703(97)70091-7","journal-title":"Am Heart J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.20603","article-title":"Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature","volume":"81","author":"Tam DH","year":"2006","unstructured":"Tam DH, Farber HW. Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature. Am J Hematol. 2006, 81:443-447. 10.1002\/ajh.20603","journal-title":"Am J Hematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V83.2.561.561","article-title":"Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin \u03b2-thalassemia intermedia patients","volume":"83","author":"Galanello R","year":"1994","unstructured":"Galanello R, Barella S, Turco M, et al.. Serum erythropoietin and erythropoiesis in high- and low-fetal hemoglobin \u03b2-thalassemia intermedia patients. Blood. 1994, 83:561-565. 10.1182\/blood.V83.2.561.561","journal-title":"Blood"},{"key":"ref18","article-title":"Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia","volume":"91","author":"Aessopos A","year":"2006","unstructured":"Aessopos A, Kati M, Tsironi M, Polonifi E, Farmakis D. Exchange blood transfusions for the treatment of leg ulcerations in thalassemia intermedia. Haematologica. 2006, 91:37-38.","journal-title":"Haematologica"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2450\/2013.0181-13","article-title":"Thalassaemia intermedia: the role of erythroexchange in the treatment of an indolent wound","volume":"12","author":"Pignatti M","year":"2014","unstructured":"Pignatti M, Govoni M, Graldi G, Pacchioni L, De Santis G, Borgna C. Thalassaemia intermedia: the role of erythroexchange in the treatment of an indolent wound. Blood Transfus. 2014, 12:124-126. 10.2450\/2013.0181-13","journal-title":"Blood Transfus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14575","article-title":"Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload","volume":"58","author":"Dedeken L","year":"2018","unstructured":"Dedeken L, L\u00ea PQ, Rozen L, et al.. Automated RBC exchange compared to manual exchange transfusion for children with sickle cell disease is cost-effective and reduces iron overload. Transfusion. 2018, 58:1356-1362. 10.1111\/trf.14575","journal-title":"Transfusion"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/50875-red-blood-cell-exchange-in-a-patient-with-extramedullary-hematopoiesis-and-cor-pulmonale-secondary-to-beta-thalassemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:21Z","timestamp":1707507021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/50875-red-blood-cell-exchange-in-a-patient-with-extramedullary-hematopoiesis-and-cor-pulmonale-secondary-to-beta-thalassemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.13638","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}